Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death. Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, we demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which we term necroptosis. We showed that necroptosis is characterized by necrotic cell death morphology and activation of autophagy. We identified a specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, which blocks a critical step in necroptosis. We demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection. Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necroptosis is a form of RCD initiated by perturbations of the extracellular or intracellular microenvironment detected by specific death receptors, including (but not limited to) FAS and TNFR1 [423–427], or pathogen recognition receptors (PRRs), including TLR3, TLR4, and Z-DNA binding protein 1 (ZBP1; also known as DAI) [428–430].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
In the citing paper
“Accordingly, chemical inhibitors of RIPK1 including necrostatin-1 (Nec-1) and derivatives (e.g., Nec-1s) robustly inhibit TNFR1-driven necroptosis, in vitro and in vivo [425, 427].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Self-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Activation of autophagy by necroptotic signaling Autophagy, a large-scale protein degradation and catabolic mechanis”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“4e and data not shown), in autophagy-deficient Atg5 −/− MEF cell”
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394
Self-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“, has been implicated in caspase-independent cell deat”
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312 · cited 10×
“2f), whereas it completely inhibited the appearance of necrotic morphology (nuclear condensation, organelle swelling, early loss of plasma membrane integrity and Nec-1 0 20 40 60 80 100 V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% )…”
InfluentialIntracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Cited by
Items 201–300 of 1,015
Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium
Matsuzawa-Ishimoto, Y., Shono, Y., Gomez, L. E., Hubbard-Lucey, V. M., Cammer, M., Neil, J., Dewan, M. Z., Lieberman, S. R., Lazrak, A., Marinis, J. M., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170558 · Cited by 291
“We found that decreased viability of Atg16L1 Δ IEC organoids treated with Z-VAD-FMK was reversed by the RIPK1 inhibitor Necrostatin-1 (Nec-1; Degterev et al., 2005; Fig.”
Harris, P. A., King, B. W., Bandyopadhyay, D., Berger, S. B., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Dong, X., Finger, J. N., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01898 · Cited by 274
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
Najjar, M., Saleh, D., Zelic, M., Nogusa, S., Shah, S., Tai, A., Finger, J. N., Polykratis, A., Gough, P. J., Bertin, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.007 · Cited by 284
“Article RIPK1 and RIPK3 Kinases Promote Cell-DeathIndependent Inflammation by Toll-like Receptor 4 Graphical Abstract Highlights d RIPK1 and RIPK3 kinases promote TRIF-dependent cytokine production by LPS in vitro d RIPK1 and RIPK3 kinase-dependent inflammation is independent of cell death d Erk1/2 mediates RIPK1 and…”
InfluentialSelf-citationCytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis
Mulay, S. R., Desai, J., Kumar, S. V., Eberhard, J. N., Thomasova, D., Romoli, S., Grigorescu, M., Kulkarni, O. P., Popper, B., Vielhauer, V., et al. (2016) · Nature Communications · doi:10.1038/ncomms10274 · Cited by 278
Chaabane, W., User, S. D., El-Gazzah, M., Jaksik, R., Sajjadi, E., Rzeszowska-Wolny, J., & Łos, M. J. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0205-y · Cited by 282
“cells and FasL-induced necrosis in Jurkat cells that are pretreated with zVAD-fmk caspase inhibitor or deficient in FADD (Degterev et al. 2005).”
BackgroundFerroptosis and Necroptosis in the Kidney
Belavgeni, A., Meyer, C., Stumpf, J., Hugo, C., & Linkermann, A. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.03.016 · Cited by 275
Baldwin, A. S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01095.x · Cited by 277
“This process is now called necroptosis (105).”
Regulated Cell Death: Signaling and Mechanisms
Ashkenazi, A., & Salvesen, G. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013226 · Cited by 274
“…er so na l u se o nl y. Yuan identified a small molecule compound, called Necrostatin-1 (Nec-1), that could inhibit this unusual type of cell death (Degterev et al. 2005); furthermore, they identified RIPK1 as the molecular target of Nec-1, thus reinforcing its importance in mediating necrotic…”
BackgroundLewerenz, J., Ates, G., Methner, A., Conrad, M., & Maher, P. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00214 · Cited by 275
“These include necroptosis (Degterev et al., 2005), parthanatos (Andrabi et al., 2006), oxytosis (Tan et al., 2001a), and ferroptosis (Dixon et al., 2012), to name a few.”
BackgroundNecroptosis: An emerging form of programmed cell death
Wu, W., Liu, P., & Li, J. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.08.004 · Cited by 270
“Inhibition of PARP fails to protect Jurkat cells rom necroptosis, indicating that PARP activation is potenially not be involved in necroptosis [50].”
BackgroundInfluentialNecrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
Cao, L., & Mu, W. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105297 · Cited by 266
“2A), a type of alkaloid with small molecule weight, was first identified as an inhibitor of necrotic cell death in 2005 [23] and was found to be a specific inhibitor of RIP1 in further studies [24].”
BackgroundTargeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 231
You, Z., Savitz, S. I., Yang, J., Degterev, A., Yuan, J., Cuny, G. D., Moskowitz, M. A., & Whalen, M. J. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.44 · Cited by 269
“Necrostatin-1, a specific inhibitor of necroptosis (Degterev et al. 2005), reduced acute cellular injury, brain tissue damage, motor dysfunction, and spatial learning deficits after CCI in mice.”
BackgroundMethodResultInfluentialSelf-citationWang, J.-X., Zhang, X.-J., Li, Q., Wang, K., Wang, Y., Jiao, J.-Q., Feng, C., Teng, S., Zhou, L.-Y., Gong, Y., et al. (2015) · Circulation Research · doi:10.1161/circresaha.117.305781 · Cited by 268
Chen, W., Zhou, Z., Li, L., Zhong, C.-Q., Zheng, X., Wu, X., Zhang, Y., Ma, H., Huang, D., Li, W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435545 · Cited by 266
“This kind of programmed cell deathwas given the name “necroptosis” (1).”
BackgroundMolecular Mechanisms of Apoptosis in Cerebral Ischemia: Multiple Neuroprotective Opportunities
Nakka, V. P., Gusain, A., Mehta, S. L., & Raghubir, R. (2008) · Molecular Neurobiology · doi:10.1007/s12035-007-8013-9 · Cited by 261
“tosis characterized by necrotic cell death morphology, and activation autophagy, have been described, which might contribute to delayed ischemic brain injury [105].”
BackgroundEmerging roles for lipids in non-apoptotic cell death
Magtanong, L., Ko, P. J., & Dixon, S. J. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.25 · Cited by 260
“In the presence of caspase inhibitors, TNF-α induces the formation of a multiprotein complex, called the necrosome, that promotes necroptosis.(4) In this pathway,”
BackgroundMolecular mechanisms of regulated necrosis
Galluzzi, L., Kepp, O., Krautwald, S., Kroemer, G., & Linkermann, A. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.02.006 · Cited by 258
“The term “necroptosis” has originally been introduced in 2005 to indicate a necrostatin 1 (Nec-1)inhibitable, and hence RIPK1-dependent, regulated form of non-apoptotic cell death triggered by TNFα receptor 1 (TNFR1) in the presence of genetic or pharmacological caspase inhibition [14].”
BackgroundStructural Basis of RIP1 Inhibition by Necrostatins
Xie, T., Peng, W., Liu, Y., Yan, C., Maki, J., Degterev, A., Yuan, J., & Shi, Y. (2013) · Structure · doi:10.1016/j.str.2013.01.016 · Cited by 248
Self-citationProgrammed Cell Death: Molecular Mechanisms and Implications for Safety Assessment of Nanomaterials
Andón, F. T., & Fadeel, B. (2013) · Accounts of Chemical Research · doi:10.1021/ar300020b · Cited by 258
The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Azam, S., Haque, M. E., Balakrishnan, R., Kim, I.-S., & Choi, D.-K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683459 · Cited by 255
Maltese, W. A., & Overmeyer, J. H. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.02.028 · Cited by 248
Determination of apoptotic and necrotic cell death in vitro and in vivo
Vanden Berghe, T., Grootjans, S., Goossens, V., Dondelinger, Y., Krysko, D. V., Takahashi, N., & Vandenabeele, P. (2013) · Methods · doi:10.1016/j.ymeth.2013.02.011 · Cited by 249
Photoreceptor cell death and rescue in retinal detachment and degenerations
Murakami, Y., Notomi, S., Hisatomi, T., Nakazawa, T., Ishibashi, T., Miller, J. W., & Vavvas, D. G. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.08.001 · Cited by 247
“This RIP kinase-dependent regulated necrosis is termed as ‘necroptosis’ or ‘programmed necrosis’ (Chan et al., 2003; Degterev et al., 2005).”
InfluentialRosenbaum, D. M., Degterev, A., David, J., Rosenbaum, P. S., Roth, S., Grotta, J. C., Cuny, G. D., Yuan, J., & Savitz, S. I. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22314 · Cited by 251
“These results together with prior work (Degterev et al., 2005) provide strong evidence that necroptosis is a significant cell death pathway in conditions involving neuronal injury.”
BackgroundResultInfluentialSelf-citationRIP kinases as modulators of inflammation and immunity
He, S., & Wang, X. (2018) · Nature Immunology · doi:10.1038/s41590-018-0188-x · Cited by 245
Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
Geserick, P., Hupe, M., Moulin, M., Wong, W. W.-L., Feoktistova, M., Kellert, B., Gollnick, H., Silke, J., & Leverkus, M. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200904158 · Cited by 246
“RIP1, and specifically its DD, was reported to be critical for CD95-mediated necrosis independent of NF-B–inducing activity or RIP1 kinase (RIP1K) activity (Holler et al., 2000; Degterev et al., 2005).”
Programmed Cell Death in Parkinson's Disease
Venderova, K., & Park, D. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009365 · Cited by 247
“Necroptosis is sometimes referred to as the “programmed necrosis” (Degterev et al. 2005) and can be described as an “ordered cellular explosion” (Vandenabeele et al.”
BackgroundCuchet-Lourenço, D., Eletto, D., Wu, C., Plagnol, V., Papapietro, O., Curtis, J., Ceron-Gutierrez, L., Bacon, C. M., Hackett, S., Alsaleem, B., et al. (2018) · Science · doi:10.1126/science.aar2641 · Cited by 243
Structure–activity relationship study of novel necroptosis inhibitors
Teng, X., Degterev, A., Jagtap, P., Xing, X., Choi, S., Denu, R., Yuan, J., & Cuny, G. D. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.077 · Cited by 237
Self-citationJain, M. V., Paczulla, A. M., Klonisch, T., Dimgba, F. N., Rao, S. B., Roberg, K., Schweizer, F., Lengerke, C., Davoodpour, P., Palicharla, V. R., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12001 · Cited by 240
Iannielli, A., Bido, S., Folladori, L., Segnali, A., Cancellieri, C., Maresca, A., Massimino, L., Rubio, A., Morabito, G., Caporali, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.089 · Cited by 239
“Importantly, specific necroptosis inhibitors, such as necrostatin-1 (Nec-1), have been developed by targeting the kinase activity of RIPK1/3 (Degterev et al., 2005).”
BackgroundApoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection
Orzalli, M. H., & Kagan, J. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.05.007 · Cited by 238
“Rather, necroptosis is inhibited by pro-apoptotic caspase-8 [48, 49].”
BackgroundGuidelines for evaluating myocardial cell death
Mishra, P. K., Adameova, A., Hill, J. A., Baines, C. P., Kang, P. M., Downey, J. M., Narula, J., Takahashi, M., Abbate, A., Piristine, H. C., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00259.2019 · Cited by 236
“The paradigm that cells with a ruptured plasma membrane die due to an accidental, chaotic, and unregulated cell death was discredited in 2005 with the recognition that tumor necrosis factor- (TNF ), a cytokine known to trigger the canonical extrinsic apoptosis pathway, can cause cell loss manifesting with the necrotic…”
BackgroundLysosomal membrane permeabilization in cell death: Concepts and challenges
Repnik, U., Hafner Česen, M., & Turk, B. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.06.006 · Cited by 233
“…is necroptosis, which ismediated through receptor-interacting protein kinase 1 (RIP1) (Vanden Berghe et al., 2010) or RIP3-MLKL (mixed lineage kinase domain-like) (Kaiser et al., 2013; Zhang et al., 2009) and which can be inhibited with the RIP1 inhibitor necrostatin-1 (Degterev et al., 2005).”
BackgroundLiang, C.-C., Wang, C., Peng, X., Gan, B., & Guan, J.-L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072389 · Cited by 235
Li, J.-X., Feng, J.-M., Wang, Y., Li, X.-H., Chen, X.-X., Su, Y., Shen, Y.-Y., Chen, Y., Xiong, B., Yang, C.-H., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.241 · Cited by 233
PMA and crystal‐induced neutrophil extracellular trap formation involves RIPK1‐RIPK3‐MLKL signaling
Desai, J., Kumar, S. V., Mulay, S. R., Konrad, L., Romoli, S., Schauer, C., Herrmann, M., Bilyy, R., Müller, S., Popper, B., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201545605 · Cited by 233
Wang, X., Li, Y., Liu, S., Yu, X., Li, L., Shi, C., He, W., Li, J., Xu, L., Hu, Z., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412767111 · Cited by 230
Self-citationChassagnon, I. R., McCarthy, C. A., Chin, Y. K.-Y., Pineda, S. S., Keramidas, A., Mobli, M., Pham, V., De Silva, T. M., Lynch, J. W., Widdop, R. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614728114 · Cited by 231
“%) at 6 h after MCAO (38), whereas Hi1a provides much higher levels of protection at up to 8 h after stroke induction.”
BackgroundInfluentialActive Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis
Overmeyer, J. H., Kaul, A., Johnson, E. E., & Maltese, W. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2036 · Cited by 229
“These include type II or autophagic cell death (5, 7, 12), paraptosis (37, 38), oncosis (39-41), and necroptosis (42, 43).”
BackgroundMechanisms of necroptosis in T cells
Ch’en, I. L., Tsau, J. S., Molkentin, J. D., Komatsu, M., & Hedrick, S. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110251 · Cited by 230
“For example, both necroptosis and ischemia reperfusion death can be blocked by necrostatin-1 (Degterev et al., 2005, 2008; Ch’en et al., 2008).”
BackgroundTumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Ruder, B., Atreya, R., & Becker, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081887 · Cited by 228
“This kind of cell death is termed classical necroptosis [62].”
BackgroundVanlangenakker, N., Bertrand, M. J. M., Bogaert, P., Vandenabeele, P., & Vanden Berghe, T. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.111 · Cited by 233
Macrophage Death as a Pharmacological Target in Atherosclerosis
Martinet, W., Coornaert, I., Puylaert, P., & De Meyer, G. R. Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00306 · Cited by 221
Lytic cell death in metabolic liver disease
Gautheron, J., Gores, G. J., & Rodrigues, C. M. P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.001 · Cited by 225
“showed that necrostatin-1, a chemical compound that blocks the kinase activity of RIPK1, was able to inhibit cell death in TNF-treated cell lines [7].”
BackgroundSecondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications
Silva, M. T., do Vale, A., & dos Santos, N. M. N. (2008) · Apoptosis · doi:10.1007/s10495-008-0187-8 · Cited by 223
“These paradigmatic modes of cell death have been observed in multicellular organisms, but less clearcut, intermediate or hybrid cell death modes have also been described as indicated by the use of terms as apoptosis-like or necrosis-like cell deaths [12], necrapoptosis [21] and necroptosis [22].”
BackgroundCoxsackievirus B3 Replication and Pathogenesis
Garmaroudi, F. S., Marchant, D., Hendry, R., Luo, H., Yang, D., Ye, X., Shi, J., & McManus, B. M. (2015) · Future Microbiology · doi:10.2217/fmb.15.5 · Cited by 228
Reactive astrocytes undergo M1 microglia/macrohpages-induced necroptosis in spinal cord injury
Fan, H., Zhang, K., Shan, L., Kuang, F., Chen, K., Zhu, K., Ma, H., Ju, G., & Wang, Y.-Z. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0081-8 · Cited by 223
“Inhibiting receptorinteracting protein 1 (RIP1) or depleting RIP3 not only significantly attenuated astrocyte death but also rescued the neurotrophic function of astrocytes.”
BackgroundMethodInfluentialRegulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 215
Pietkiewicz, S., Schmidt, J. H., & Lavrik, I. N. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.04.025 · Cited by 223
Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells
Pizato, N., Luzete, B. C., Kiffer, L. F. M. V., Corrêa, L. H., de Oliveira Santos, I., Assumpção, J. A. F., Ito, M. K., & Magalhães, K. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-20422-0 · Cited by 224
TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer
Walczak, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01066.x · Cited by 226
“However, the recent discovery of necroptosis (101), a regulated pathway of necrosis induction, also referred to as regulated necrosis or programmed necrosis, revived the interest in the mechanisms leading to this form of cell death (102–105).”
BackgroundChen, X., Tsvetkov, A. S., Shen, H.-M., Isidoro, C., Ktistakis, N. T., Linkermann, A., Koopman, W. J. H., Simon, H.-U., Galluzzi, L., Luo, S., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2319901 · Cited by 206
Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke
Yuan, J. (2009) · Apoptosis · doi:10.1007/s10495-008-0304-8 · Cited by 223
“A family of small molecule inhibitors of necroptosis, termed necrostatins, were identified using high throughput cell-based screens [51, 52, 55, 56].”
BackgroundSelf-citationNajafov, A., Chen, H., & Yuan, J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.03.002 · Cited by 223
“The discovery of the small molecule Nec-1 (methyl-thiohydantoin-Trp) and its improved analog Nec-1s (7-Cl-O-Nec-1) [5-(7-chloro-1H-indol-3-yl)methyl)-3-methylimidazolidine-2,4-dione] as highly effective and specific inhibitors of necroptosis played an important role in defining this regulated necrotic cell death mecha…”
Self-citationThe double-edged functions of necroptosis
Ye, K., Chen, Z., & Xu, Y. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05691-6 · Cited by 214
“In 2005, necroptosis was described as a novel, TNF-α-triggered, non-apoptotic form of cell death occurring in the absence of caspase-8 [3].”
BackgroundAfonso, M. B., Rodrigues, P. M., Carvalho, T., Caridade, M., Borralho, P., Cortez-Pinto, H., Castro, R. E., & Rodrigues, C. M. P. (2015) · Clinical Science · doi:10.1042/cs20140732 · Cited by 221
Fan, H., Tang, H.-B., Shan, L.-Q., Liu, S.-C., Huang, D.-G., Chen, X., Chen, Z., Yang, M., Yin, X.-H., Yang, H., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1613-2 · Cited by 218
Neuronal Apoptosis in Neurodegeneration
Okouchi, M., Ekshyyan, O., Maracine, M., & Aw, T. Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1511 · Cited by 218
“:3) stimulation (73).”
Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery
Kovacs, J. R., Li, C., Yang, Q., Li, G., Garcia, I. G., Ju, S., Roodman, D. G., Windle, J. J., Zhang, X., & Lu, B. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.78 · Cited by 219
Puyal, J., Ginet, V., & Clarke, P. G. H. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.03.002 · Cited by 213
“…of lysosomal proteases (Seyfried et al., 1997; Wen et al., 2008), found an increased expression of autophagosomal marker LC3-II by Western blot (Degterev et al., 2005; Ginet et al., 2009; Puyal et al., 2009; Zhu et al., 2005) and showed increased numbers of autophagosomes and autolysosomes by…”
BackgroundInfluentialResolution of inflammation: Mechanisms and opportunity for drug development
Alessandri, A. L., Sousa, L. P., Lucas, C. D., Rossi, A. G., Pinho, V., & Teixeira, M. M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.006 · Cited by 213
“Until recently, necrosis was considered a non-specific mode of cell death, but a body of evidence has demonstrated that certain types of necrosis are finely regulated by signal transduction pathways leading to the term necroptosis (programmed necrosis) (Degterev et al., 2005; Han et al., 2011).”
Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets
De Meyer, G. R. Y., Zurek, M., Puylaert, P., & Martinet, W. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00957-0 · Cited by 202
“Since the discovery, in 2005, of necrostatins — small molecules that inhibit cell death mediated by receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in TNF-treated cells 46,47 — necrosis is no longer considered to be unregulated.”
Metal-Based Photosensitizers as Inducers of Regulated Cell Death Mechanisms
Zhang, Y., Doan, B.-T., & Gasser, G. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00161 · Cited by 213
New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy
Long, J. S., & Ryan, K. M. (2012) · Oncogene · doi:10.1038/onc.2012.7 · Cited by 214
Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase
Degterev, A., Maki, J. L., & Yuan, J. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.133 · Cited by 212
Self-citationNecroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression
Zhu, K., Liang, W., Ma, Z., Xu, D., Cao, S., Lu, X., Liu, N., Shan, B., Qian, L., & Yuan, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0524-y · Cited by 217
Self-citationEssential role for autophagy in the maintenance of immunological memory against influenza infection
Chen, M., Hong, M. J., Sun, H., Wang, L., Shi, X., Gilbert, B. E., Corry, D. B., Kheradmand, F., & Wang, J. (2014) · Nature Medicine · doi:10.1038/nm.3521 · Cited by 213
Molecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 209
“In other cell contexts, a RIP3 dependent ROS production may play an additional role [144,145].”
BackgroundBasit, F., Cristofanon, S., & Fulda, S. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.45 · Cited by 211
“To address this question, we used necrostatin-1 (Nec-1), a RIP1-specific inhibitor that has been reported to block necroptosis.(31) Of note, Nec-1 significantly rescued GX15-070-induced loss of cell viability (Figure 6a), demonstrating that RIP1 kinase activity is required for GX15070-triggered cell death.”
MethodMathematical Modelling of Cell-Fate Decision in Response to Death Receptor Engagement
Calzone, L., Tournier, L., Fourquet, S., Thieffry, D., Zhivotovsky, B., Barillot, E., & Zinovyev, A. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000702 · Cited by 215
“This RIP1-dependent cytokineinduced necrotic death defines necroptosis [15,16].”
Origin and Consequences of Necroinflammation
Sarhan, M., Land, W. G., Tonnus, W., Hugo, C. P., & Linkermann, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00041.2016 · Cited by 207
The ‘complexities’ of life and death: Death receptor signalling platforms
Dickens, L. S., Powley, I. R., Hughes, M. A., & MacFarlane, M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.005 · Cited by 208
“Necrosis, conversely, has long been considered to occur in a non-regulated fashion, however the discovery of necrotic morphology following treatment of cells with death ligands, in the absence of caspase activation, lead to the concept of necroptosis or programmed necrosis [1].”
BackgroundInfluentialMechanisms and Models of Kidney Tubular Necrosis and Nephron Loss
Maremonti, F., Meyer, C., & Linkermann, A. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021101293 · Cited by 197
A novel role for RIP1 kinase in mediating TNFα production
Christofferson, D. E., Li, Y., Hitomi, J., Zhou, W., Upperman, C., Zhu, H., Gerber, S. A., Gygi, S., & Yuan, J. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.64 · Cited by 210
“RIP1 kinase and necroptosis are activated by death receptor ligands, such as TNFa and Fas, when apoptosis is blocked.(1,3) Necrostatin-1 (Nec-1), a small molecule inhibitor of RIP1 kinase activity, can also block necroptosis.”
BackgroundSelf-citationTumor necrosis factor-mediated cell death: to break or to burst, that’s the question
Van Herreweghe, F., Festjens, N., Declercq, W., & Vandenabeele, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0283-0 · Cited by 205
“In vitro, Nec-1 inhibits TNF-induced necrosis in L929 cells and FasL-induced necrosis in Jurkat cells deficient in FADD or pretreated with zVAD-fmk [80].”
InfluentialChallenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
Röhrig, U. F., Majjigapu, S. R., Vogel, P., Zoete, V., & Michielin, O. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00326 · Cited by 204
Necrostatin Decreases Oxidative Damage, Inflammation, and Injury after Neonatal HI
Northington, F. J., Chavez-Valdez, R., Graham, E. M., Razdan, S., Gauda, E. B., & Martin, L. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.72 · Cited by 204
MG53 Constitutes a Primary Determinant of Cardiac Ischemic Preconditioning
Cao, C.-M., Zhang, Y., Weisleder, N., Ferrante, C., Wang, X., Lv, F., Zhang, Y., Song, R., Hwang, M., Jin, L., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.954628 · Cited by 204
Cerebral ischemia and neuroregeneration
Lin, H., Lee, R. C., Lee, M. H., Wu, C. C., Couto e Silva, A., Possoit, H., Hsieh, T.-H., & Minagar, A. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.228711 · Cited by 204
“…cellular excitotoxicity, cerebral ischemia alone can induce overexpression of the death receptor ligands (i.e., tumor necrosis factor (TNF)-α and FasL), as a result of serine/threonine-protein kinase 1-mediated neuronal necroptosis (Holler et al., 2000; Degterev et al., 2005, 2008).”
BackgroundRIPK3-Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival
Lau, A., Wang, S., Jiang, J., Haig, A., Pavlosky, A., Linkermann, A., Zhang, Z.-X., & Jevnikar, A. M. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12447 · Cited by 204
“As necroptosis is a ‘‘failsafe’’ mechanism to eliminate caspase-8 inhibiting virus infections (32,33), inhibition of caspase-8 may be detrimental by triggering necroptosis.”
BackgroundTargeting ferroptosis in breast cancer
Li, Z., Chen, L., Chen, C., Zhou, Y., Hu, D., Yang, J., Chen, Y., Zhuo, W., Mao, M., Zhang, X., et al. (2020) · Biomarker Research · doi:10.1186/s40364-020-00230-3 · Cited by 200
Entosis Is Induced by Glucose Starvation
Hamann, J. C., Surcel, A., Chen, R., Teragawa, C., Albeck, J. G., Robinson, D. N., & Overholtzer, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.037 · Cited by 203
“For example, regulated forms of necrosis (necroptosis [Degterev et al., 2005] and ferroptosis [Dixon et al., 2012]) and autophagic cell death are now known to contribute to cell death induced by viral infection (Linkermann and Green, 2014) and nutrient deprivation (Gao et al., 2015; Liu et al.,…”
Molecular crosstalk between apoptosis, necroptosis, and survival signaling
Vanden Berghe, T., Kaiser, W. J., Bertrand, M. J., & Vandenabeele, P. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975093 · Cited by 205
Remijsen, Q., Goossens, V, Grootjans, S., Van den Haute, C., Vanlangenakker, N., Dondelinger, Y., Roelandt, R., Bruggeman, I., Goncalves, A., Bertrand, M. J. M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.531 · Cited by 202
Pathophysiology of glia in perinatal white matter injury
Back, S. A., & Rosenberg, P. A. (2014) · Glia · doi:10.1002/glia.22658 · Cited by 202
“In addition, necrostatin was very effective at blocking the production of ROS, although it is not a free radical scavenger (Degterev et al., 2005).”
BackgroundInfluentialXia, B., Fang, S., Chen, X., Hu, H., Chen, P., Wang, H., & Gao, Z. (2016) · Cell Research · doi:10.1038/cr.2016.26 · Cited by 202
Mitochondria released by cells undergoing TNF-α-induced necroptosis act as danger signals
Maeda, A., & Fadeel, B. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.277 · Cited by 201
“The latter finding is in line with previous work by Degterev et al.3 who noted swelling of mitochondria (within dying cells) during necroptosis.”
BackgroundResultControl of Life-or-Death Decisions by RIP1 Kinase
Christofferson, D. E., Li, Y., & Yuan, J. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170259 · Cited by 201
Self-citationOu, L., Lin, S., Song, B., Liu, J., Lai, R., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140526 · Cited by 199
Cell death in health and disease
Lockshin, R. A., & Zakeri, Z. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00150.x · Cited by 200
Mechanisms of Photoreceptor Death in Retinitis Pigmentosa
Newton, F., & Megaw, R. (2020) · Genes · doi:10.3390/genes11101120 · Cited by 195
“Necroptosis is regulated by the interaction between two receptor interacting protein kinases (RIP1 and RIP3) [17,18].”
BackgroundReactive Oxygen Species in TNFα-Induced Signaling and Cell Death
Morgan, M. J., & Liu, Z.-G. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0105-0 · Cited by 195
“A novel drug that prevents programmed necrotic cell death has been recently developed, and appears to be an inhibitor of RIPK1 kinase activity (Degterev et al., 2005; 2008).”
BackgroundThe Jekyll and Hyde Functions of Caspases
Yi, C. H., & Yuan, J. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.012 · Cited by 200
“This type of necrotic cell death, which has been termed necroptosis (Degterev et al., 2005), can be effectively inhibited by a RIP1 kinase inhibitor, necrostatin-1 (Nec-1) (Bell et al., 2008; Ch’en et al., 2008).”
Self-citationNecroptosis in neurodegenerative diseases: a potential therapeutic target
Zhang, S., Tang, M.-B., Luo, H.-Y., Shi, C.-H., & Xu, Y.-M. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.286 · Cited by 197
“increasing studies have described a genetically programmed and regulated form of necrosis, termed necroptosis.(3,4)”
BackgroundNatural products to prevent drug resistance in cancer chemotherapy: a review
Yuan, R., Hou, Y., Sun, W., Yu, J., Liu, X., Niu, Y., Lu, J., & Chen, X. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13387 · Cited by 196
The Invasive Chytrid Fungus of Amphibians Paralyzes Lymphocyte Responses
Fites, J. S., Ramsey, J. P., Holden, W. M., Collier, S. P., Sutherland, D. M., Reinert, L. K., Gayek, A. S., Dermody, T. S., Aune, T. M., Oswald-Richter, K., et al. (2013) · Science · doi:10.1126/science.1243316 · Cited by 193
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Mohammed, S., Thadathil, N., Selvarani, R., Nicklas, E. H., Wang, D., Miller, B. F., Richardson, A., & Deepa, S. S. (2021) · Aging Cell · doi:10.1111/acel.13512 · Cited by 192
“For example, circulating levels of TNFa, a well-known inducer of necroptosis (Degterev et al., 2005) have been reported to increase with age in humans (Bruunsgaard et al.”
BackgroundA cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
Fauster, A., Rebsamen, M., Huber, K. V. M., Bigenzahn, J. W., Stukalov, A., Lardeau, C.-H., Scorzoni, S., Bruckner, M., Gridling, M., Parapatics, K., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.130 · Cited by 188
Metadata
- Authors
- Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yuan, Junying
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2005-05-29
- Volume
- 1
- Issue
- 2
- Pages
- 112-119
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2110796758
- Cited by
- 3,068
- References
- 39
- Citations by year
- 2026: 144 · 2025: 217 · 2024: 239 · 2023: 240 · 2022: 237 · 2021: 208 · 2020: 181 · 2019: 150 · 2018: 190 · 2017: 171 · 2016: 161 · 2015: 150 · 2014: 180 · 2013: 126 · 2012: 111
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Update notices
- addendum (2013-02-15)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institute on Aging (R37AG012859)
- National Institute of General Medical Sciences (R01GM064703, R01 GM64703)
- National Institute of Neurological Disorders and Stroke (R01NS037141, R01 NS37141-08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- necroptosis, non-apoptotic cell death, necrostatin-1, ischemic brain injury, stroke, neuroprotection, autophagy, regulated cell death, small molecule inhibitors
- MeSH terms
- Animals, Brain Ischemia, Humans, Imidazoles, Indoles, Molecular Structure, Signal Transduction, Cell Death, Protein Serine-Threonine Kinases, Cell Line, Tumor, Protein Kinase Inhibitors, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.